135 related articles for article (PubMed ID: 30345534)
1. A role for paracrine interleukin-6 signaling in the tumor microenvironment in prostate tumor growth.
Yu SH; Maynard JP; Vaghasia AM; De Marzo AM; Drake CG; Sfanos KS
Prostate; 2019 Feb; 79(2):215-222. PubMed ID: 30345534
[TBL] [Abstract][Full Text] [Related]
2. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
Peek EM; Song W; Zhang H; Huang J; Chin AI
Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486
[TBL] [Abstract][Full Text] [Related]
3. The effects of aging on tumor growth and angiogenesis are tumor-cell dependent.
Reed MJ; Karres N; Eyman D; Cruz A; Brekken RA; Plymate S
Int J Cancer; 2007 Feb; 120(4):753-60. PubMed ID: 17131319
[TBL] [Abstract][Full Text] [Related]
4. Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer.
Ronca R; Alessi P; Coltrini D; Di Salle E; Giacomini A; Leali D; Corsini M; Belleri M; Tobia C; Garlanda C; Bonomi E; Tardanico R; Vermi W; Presta M
J Pathol; 2013 Jun; 230(2):228-38. PubMed ID: 23424081
[TBL] [Abstract][Full Text] [Related]
5. Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells.
Wu CT; Hsieh CC; Lin CC; Chen WC; Hong JH; Chen MF
J Mol Med (Berl); 2012 Nov; 90(11):1343-55. PubMed ID: 22660275
[TBL] [Abstract][Full Text] [Related]
6. Versatile prostate cancer treatment with inducible caspase and interleukin-12.
Nikitina EY; Desai SA; Zhao X; Song W; Luo AZ; Gangula RD; Slawin KM; Spencer DM
Cancer Res; 2005 May; 65(10):4309-19. PubMed ID: 15899823
[TBL] [Abstract][Full Text] [Related]
7. Disruption of arginase II alters prostate tumor formation in TRAMP mice.
Mumenthaler SM; Rozengurt N; Livesay JC; Sabaghian A; Cederbaum SD; Grody WW
Prostate; 2008 Oct; 68(14):1561-9. PubMed ID: 18663728
[TBL] [Abstract][Full Text] [Related]
8. TLR7 expression is decreased during tumour progression in transgenic adenocarcinoma of mouse prostate mice and its activation inhibits growth of prostate cancer cells.
Han JH; Park SY; Kim JB; Cho SD; Kim B; Kim BY; Kang MJ; Kim DJ; Park JH; Park JH
Am J Reprod Immunol; 2013 Oct; 70(4):317-26. PubMed ID: 23790156
[TBL] [Abstract][Full Text] [Related]
9. Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice.
Sun F; Zhang ZW; Tan EM; Lim ZLR; Li Y; Wang XC; Chua SE; Li J; Cheung E; Yong EL
Carcinogenesis; 2016 Jul; 37(7):701-711. PubMed ID: 27207661
[TBL] [Abstract][Full Text] [Related]
10. Genetic ablation of the amplified-in-breast cancer 1 inhibits spontaneous prostate cancer progression in mice.
Chung AC; Zhou S; Liao L; Tien JC; Greenberg NM; Xu J
Cancer Res; 2007 Jun; 67(12):5965-75. PubMed ID: 17575167
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer-derived cathelicidin-related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic macrophages.
Cha HR; Lee JH; Hensel JA; Sawant AB; Davis BH; Lee CM; Deshane JS; Ponnazhagan S
Prostate; 2016 May; 76(7):624-36. PubMed ID: 26856684
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy.
Mikyšková R; Štěpánek I; Indrová M; Bieblová J; Šímová J; Truxová I; Moserová I; Fučíková J; Bartůňková J; Špíšek R; Reiniš M
Int J Oncol; 2016 Mar; 48(3):953-64. PubMed ID: 26718011
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of SOCS3 mediated by adenovirus vector in mouse and human castration-resistant prostate cancer cells increases the sensitivity to NK cells in vitro and in vivo.
Yoneda T; Kunimura N; Kitagawa K; Fukui Y; Saito H; Narikiyo K; Ishiko M; Otsuki N; Nibu KI; Fujisawa M; Serada S; Naka T; Shirakawa T
Cancer Gene Ther; 2019 Nov; 26(11-12):388-399. PubMed ID: 30607005
[TBL] [Abstract][Full Text] [Related]
14. The role of IL-6 in the radiation response of prostate cancer.
Wu CT; Chen MF; Chen WC; Hsieh CC
Radiat Oncol; 2013 Jun; 8():159. PubMed ID: 23806095
[TBL] [Abstract][Full Text] [Related]
15. Piceatannol inhibits migration and invasion of prostate cancer cells: possible mediation by decreased interleukin-6 signaling.
Kwon GT; Jung JI; Song HR; Woo EY; Jun JG; Kim JK; Her S; Park JH
J Nutr Biochem; 2012 Mar; 23(3):228-38. PubMed ID: 21497499
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice.
Kalin TV; Wang IC; Ackerson TJ; Major ML; Detrisac CJ; Kalinichenko VV; Lyubimov A; Costa RH
Cancer Res; 2006 Feb; 66(3):1712-20. PubMed ID: 16452231
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor-like protein is required for prostate tumor growth in the TRAMP mouse model.
Vasiliauskas J; Nashu MA; Pathrose P; Starnes SL; Waltz SE
Oncotarget; 2014 Jul; 5(14):5547-58. PubMed ID: 24980820
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.
Polnaszek N; Kwabi-Addo B; Peterson LE; Ozen M; Greenberg NM; Ortega S; Basilico C; Ittmann M
Cancer Res; 2003 Sep; 63(18):5754-60. PubMed ID: 14522896
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.
Wu GJ; Fu P; Chiang CF; Huss WJ; Greenberg NM; Wu MW
J Urol; 2005 May; 173(5):1778-83. PubMed ID: 15821586
[TBL] [Abstract][Full Text] [Related]
20. [Interleukin-12 over-expression in malignant melanoma B16 cells reduces programmed death-1 expression on T cells in mice with immune reconstitution].
Liu Y; Xu H; Lai N; Yang Z; Kang S
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jun; 40(6):856-863. PubMed ID: 32895201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
